SCHEMBL489031

SCHEMBL489031

CC=C(C)C(=O)OCC(C)CC(C)CO

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.36
PRKCA P17252 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL607409 0.91 TSHR (0.39) TSHRPRKCA
SCHEMBL1560861 0.86 TSHR (0.36) TSHRPRKCA
SCHEMBL7776918 0.85 PRKCA (0.34) TSHRPRKCA
SCHEMBL7779129 0.83 TSHR (0.33) TSHR
SCHEMBL489030 0.80 TSHR (0.60) TSHR
SCHEMBL10605323 0.79 MAPT (0.42) TSHR
SCHEMBL10605319 0.79 MAPT (0.42) TSHR
SCHEMBL1330746 0.79 TDP1 (0.39) TSHRPRKCA
SCHEMBL1330745 0.79 TDP1 (0.39) TSHRPRKCA
SCHEMBL1473218 0.77 TSHR (0.59) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11820844-B2 Charge-modified particles and methods of making the same 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-11-21 US claimed
EP-3768655-A1 MODIFIED ALUMINUM NITRIDE PARTICLES AND METHODS OF MAKING THE SAME 3M Innovative Properties Company (US) 2021-01-27 EP claimed
US-20210009811-A1 MODIFIED ALUMINUM NITRIDE PARTICLES AND METHODS OF MAKING THE SAME 3M INNOVATIVE PROPERTIES COMPANY 2021-01-14 US claimed
US-20210002137-A1 CHARGE-MODIFIED PARTICLES AND METHODS OF MAKING THE SAME 3M INNOVATIVE PROPERTIES COMPANY 2021-01-07 US claimed
WO-2019180619-A1 MODIFIED ALUMINUM NITRIDE PARTICLES AND METHODS OF MAKING THE SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2019-09-26 WO claimed
US-9205033-B2 Composite spherical polymer particles and their production process, and cosmetics using the same DAINICHISEIKA COLOR & CHEMICALS MFG. CO., LTD. (JP) 2015-12-08 US claimed
EP-3578375-B1 MANUFACTURING METHOD OF LAMINATE PRINTED ARTICLE FUJIFILM CORP (JP) 2024-07-17 EP disclosed
US-20240234226-A9 CURABLE COMPOSITION FOR INKJET AND AIR CAVITY FORMATION, ELECTRONIC COMPONENT, AND METHOD FOR MANUFACTURING ELECTRONIC COMPONENT SEKISUI CHEMICAL CO., LTD. (JP) 2024-07-11 US disclosed
WO-2024143370-A1 COMPOSITE PARTICLE AND LIGHT CONTROL LAMINATED BODY 積水化学工業株式会社 2024-07-04 WO disclosed
WO-2024143369-A1 COMPOSITE PARTICLE AND LIGHT CONTROL LAMINATE 積水化学工業株式会社 2024-07-04 WO disclosed
US-20240166902-A1 ACTIVE ENERGY RAY-CURABLE INKJET INK, AND PRINTED MATTER TOYO INK SC HOLDINGS CO., LTD. (JP) 2024-05-23 US disclosed
US-20240136239-A1 CURABLE COMPOSITION FOR INKJET AND AIR CAVITY FORMATION, ELECTRONIC COMPONENT, AND METHOD FOR MANUFACTURING ELECTRONIC COMPONENT SEKISUI CHEMICAL CO., LTD. (JP) 2024-04-25 US disclosed
WO-2024080336-A1 CURABLE COMPOSITION FOR INKJET USE AND FOR AIR CAVITY FORMATION, AND ELECTRONIC COMPONENT 積水化学工業株式会社 2024-04-18 WO disclosed
US-20070004823-A1 Ink composition, image forming method and printed article FUJI PHOTO FILM CO., LTD. 2007-01-04 US disclosed
EP-1739141-A1 Ink composition, image forming method and printed article Fuji Photo Film Co., Ltd. (JP) 2007-01-03 EP disclosed
US-20060257632-A1 Ink composition FUJI PHOTO FILM CO., LTD. 2006-11-16 US disclosed
EP-1721945-A1 Ink composition Fuji Photo Film Co., Ltd. (JP) 2006-11-15 EP disclosed
US-20060194029-A1 Ink composition, inkjet recording method using the same, and printed material FUJI PHOTO FILM CO., LTD. 2006-08-31 US disclosed
EP-0909752-B1 DI(METH)ACRYLATES KYOWA YUKA KK (JP) 2001-09-05 EP disclosed
EP-0909752-A1 DI(METH)ACRYLATES Kyowa Yuka Co., Ltd. (JP) 1999-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210002137-A1 CHARGE-MODIFIED PARTICLES AND METHODS OF MAKING THE SAME PCTP, MBOAT1, CA13 TSHR 1659/4885PRKCA 4055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.